XYZAL ALLERGY 24HR FDA approval date

The FDA approved XYZAL ALLERGY 24HR on 31 Jan 2017.

FDA approval date
31 Jan 2017

Drug identity has not yet been verified against registry records

Also recorded as LEVOCETIRIZINE DIHYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-01-31DayXYZAL ALLERGY 24HRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209089", "applicant_as_listed_by_fda": "CHATTEM SANOFI", "brand_names": ["XYZAL ALLERGY 24HR"], "active_ingredients": ["LEVOCETIRIZINE DIHYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170131", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026